BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 24447366)

  • 21. Related causal frameworks for surrogate outcomes.
    Joffe MM; Greene T
    Biometrics; 2009 Jun; 65(2):530-8. PubMed ID: 18759836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pseudo-Bayesian shrinkage approach to regression with missing covariates.
    Zhang N; Little RJ
    Biometrics; 2012 Sep; 68(3):933-42. PubMed ID: 22150765
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian causal inference for observational studies with missingness in covariates and outcomes.
    Zang H; Kim HJ; Huang B; Szczesniak R
    Biometrics; 2023 Dec; 79(4):3624-3636. PubMed ID: 37553770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjusting for nonignorable missingness when estimating generalized additive models.
    Xie H
    Biom J; 2010 Apr; 52(2):186-200. PubMed ID: 20422637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventive health care, 2001 update: should women be routinely taught breast self-examination to screen for breast cancer?
    Baxter N;
    CMAJ; 2001 Jun; 164(13):1837-46. PubMed ID: 11450279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Propensity score estimation with missing values using a multiple imputation missingness pattern (MIMP) approach.
    Qu Y; Lipkovich I
    Stat Med; 2009 Apr; 28(9):1402-14. PubMed ID: 19222021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.
    Rubin DB
    Stat Med; 2007 Jan; 26(1):20-36. PubMed ID: 17072897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of selected causality theories].
    Thoemmes F
    Gesundheitswesen; 2011 Dec; 73(12):880-3. PubMed ID: 22193896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of causal relations in neuroimaging data with latent confounders: An instrumental variable approach.
    Grosse-Wentrup M; Janzing D; Siegel M; Schölkopf B
    Neuroimage; 2016 Jan; 125():825-833. PubMed ID: 26518633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Causal effects in clinical and epidemiological studies via potential outcomes: concepts and analytical approaches.
    Little RJ; Rubin DB
    Annu Rev Public Health; 2000; 21():121-45. PubMed ID: 10884949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative monotonicity assumptions for improving bounds on natural direct effects.
    Chiba Y; Taguri M
    Int J Biostat; 2013 Jul; 9(2):235-49. PubMed ID: 23893690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A principal stratification approach for evaluating natural direct and indirect effects in the presence of treatment-induced intermediate confounding.
    Taguri M; Chiba Y
    Stat Med; 2015 Jan; 34(1):131-44. PubMed ID: 25312003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polydesigns and causal inference.
    Li F; Frangakis CE
    Biometrics; 2006 Jun; 62(2):343-51. PubMed ID: 16918898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An analytic method for the placebo-based pattern-mixture model.
    Lu K
    Stat Med; 2014 Mar; 33(7):1134-45. PubMed ID: 24122822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The balanced survivor average causal effect.
    Greene T; Joffe M; Hu B; Li L; Boucher K
    Int J Biostat; 2013 May; 9(2):291-306. PubMed ID: 23658214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sharp bounds on the relative treatment effect for ordinal outcomes.
    Lu J; Zhang Y; Ding P
    Biometrics; 2020 Jun; 76(2):664-669. PubMed ID: 31742664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Explanatory analyses of randomized studies.
    Tritchler D
    Biometrics; 1996 Dec; 52(4):1450-6. PubMed ID: 8962463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Bayesian Approach for Estimating the Survivor Average Causal Effect When Outcomes Are Truncated by Death in Cluster-Randomized Trials.
    Tong G; Li F; Chen X; Hirani SP; Newman SP; Wang W; Harhay MO
    Am J Epidemiol; 2023 Jun; 192(6):1006-1015. PubMed ID: 36799630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.